ScreenerHero

ADXNAddex Therapeutics Ltd

NAS · US · Healthcare · Biotechnology · addextherapeutics.com
4.940USDMkt Cap: 6.25M $P/E: —

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enz…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap6.25M $
Enterprise Value4.08M $
Revenue (TTM)109.50K $
Gross Profit-442.22K $
Net Income (TTM)-6.73M $
Revenue/Share0.1200 USD
Last Price4.940 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCH0029850754
Valuation
P/E (Trailing)—
P/E (Forward)-98.80
PEG—
EV/EBITDA-1.52
EV/Revenue37.25
P/S57.11
P/B1.18
EPS (TTM)-9.02
EPS (Forward)-0.05
52W Range
4.60024% of range6.033
52W High6.033 USD
52W Low4.600 USD
Profitability
Gross Margin0.00%
Oper. Margin-6238.81%
EBITDA Margin0.00%
Profit Margin-22448.44%
ROE-141.15%
ROA-105.72%
Growth
Revenue Growth-89.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.17M $
CapEx (TTM)—
FCF Margin-1392.47%
FCF Yield-24.38%
Net Debt-832.88K $
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.01
Current Ratio0.97
Quick Ratio0.79
Book Value/Sh4.202 USD
Cash/Share0.9400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 23, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.27M
Float808.87K
Insiders0.00%
Institutions0.01%
Short Interest
Short Ratio2.9d
Short % Float0.38%
Short % Out.0.33%
Shares Short4.15K
Short (prev mo.)1.51K
Technical
SMA 505.853 (-15.6%)
SMA 2006.989 (-29.3%)
Beta2.00
S&P 52W Chg19.18%
Avg Vol (30d)7.22M
Avg Vol (10d)750.34K
Technical Indicators
RSI (14)35.0
MACD-0.1721
MACD Signal-0.0844
MACD Hist.-0.0876
BB Upper6.410 USD
BB Middle5.649 USD
BB Lower4.889 USD
BB Width26.94%
ATR (14)0.4091 USD
Vol Ratio (20d)549.86x